NDC 47426-503-03 - ZYNRELEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47426-503
- Requested NDC
- 47426-503-03
- Package NDCs from labels
- 47426-503-03, 47426-503-01
- Manufacturer
- Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZYNRELEF | Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47426-503-01 | ZYNRELEF | 1 in 1 KIT | SOLUTION | 1 | 16 | |
| 47426-503-03 | ZYNRELEF | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 47426-503-03 | ZYNRELEF | 2.3 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 2.3 | 16 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47426-503-01 | ML - Milliliter | 47426-503 | 3ed1a242-891a-416f-84ab-cadd5abbd40a | 1 | 2025-08-11 |
| 47426-503-03 | ML - Milliliter | 47426-503 | ff282d7c-d8d6-41d1-91ae-720c61eedb07 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| meloxicam | MELOXICAM | Bryant Ranch Prepack | c51a641b-5715-4be9-baac-7fd4ec729570 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | XLCare Pharmaceuticals, Inc. | 50ecda86-d46b-4a78-b423-879f9f5c42bd | 2024-10-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Quallent Pharmaceuticals Health LLC | 2875c30d-508a-46e1-ae5a-bc7057e7cbee | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Zydus Pharmaceuticals USA Inc. | 6c015f72-5ce3-4f56-8237-776fc2165b0c | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Bryant Ranch Prepack | a381942f-0cba-4e97-4741-ad04a6af2164 | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | NuCare Pharmaceuticals, Inc. | 43ca4ab6-7d52-2954-e054-00144ff88e88 | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Camber Pharmaceuticals, Inc. | 5265e241-ab6a-400f-809f-5992f36c5593 | 2024-08-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Bryant Ranch Prepack | e5860527-f338-4073-9bb4-9f5f079469e7 | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Bryant Ranch Prepack | 3e37bece-b23e-41ca-9557-5105087e273b | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Lupin Pharmaceuticals, Inc. | 06a401f0-4380-4081-86ed-a309a25abf6b | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Unichem Pharmaceuticals (USA), Inc. | 5fe76337-eae5-4e5c-96ef-6cfa97983c6e | 2024-08-05 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | NuCare Pharmaceuticals, Inc. | 4925f194-c924-242c-e054-00144ff88e88 | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | NuCare Pharmaceuticals,Inc. | 630221ef-714e-6996-e053-2991aa0a586f | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Bupivacaine | BUPIVACAINE | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 0af296bb-1599-4b35-b66b-994924d3e898 | 2024-07-09 | Warnings, Adverse reactions | Y8335394RO |
| MELOXICAM | MELOXICAM | Proficient Rx LP | 3cc9741f-0574-485f-bbf5-027cb236736c | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | AiPing Pharmaceutical, Inc | f93806e1-88b8-4bcd-ac29-7642ab4d6cbd | 2024-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf | 2023-11-26 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | bcfca8c6-bdba-4546-97be-1fc5601c7346 | 2023-09-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | NCS HealthCare of KY, LLC dba Vangard Labs | 108397e9-672d-4061-bb74-65818c782d61 | 2023-03-07 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 49367275-4bff-4e36-8a91-e59eb07aa15f | 2022-10-05 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.